"Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?
Journal Information
Full Title: Adv Drug Deliv Rev
Abbreviation: Adv Drug Deliv Rev
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Evidence found in paper:
"Work in the author's laboratory is supported by grants from the NIH (RO1 CA102126 and R21 CA116014), the Susan G. Komen Breast Cancer Foundation (BCTR02-1194), the Department of Defense (BC050662), and the Donna and Jesse Garber Award. Many thanks to Hasmik Agadjanian, Jun Ma, Altan Rentsendorj, and Vinod Valluripalli for helpful discussions on this work, and to JC, DR, and MM-K for ongoing support."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025